Zachary Russ

Zachary Russ is a Principal Scientist and Co-Founder at Novome Biotechnologies. Zachary has also worked as a Graduate Student Researcher at UC Berkeley and an Undergraduate Researcher at the University of Maryland. As a Graduate Student Researcher, Zachary developed a glycosylation / biological protecting group - based strategy to dye denim without hazardous reducing agents. Zachary also created the first in vivo polymer exclusion assay for peroxisomal permeability and discovered new tyrosine hydroxylase activity in a P450. The technologies they developed resulted in two patent applications. As an Undergraduate Researcher, Zachary worked in Joonil Seog's lab (biomaterials) and William Bentley's lab (metabolic engineering). Zachary constructed new nanoscale structures and extended a signaling pathway to detect S-adenosyl methionine. Zachary has also had several summer undergraduate research experiences at Rice University, UC Berkeley, and Memorial Sloan-Kettering Cancer Center.

Zachary Russ earned a Doctor of Philosophy in Bioengineering from the University of California, Berkeley. Zachary also holds a Bachelor's Degree in Bioengineering from the University of Maryland, as well as a Bachelor's Degree in Mathematics from the same school. In addition, Zachary Russ is certified by CompTIA in CompTIA A+ Certification.

Zachary Russ reports to Blake Wise, Chief Executive Officer. Zachary Russ works with Lachy McLean - Chief Medical Officer, Weston Whitaker - VP of Research & Co-Founder, and Will DeLoache - CSO & Co-Founder.